Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Proteomics International Laboratories Limited
  6. News
  7. Summary
    PIQ   AU000000PIQ0

PROTEOMICS INTERNATIONAL LABORATORIES LIMITED

(PIQ)
Delayed Australian Stock Exchange  -  08:28 2022-11-28 pm EST
0.8750 AUD   +2.34%
11/10Proteomics International Laboratories Secures Hong Kong Patent for Diabetes Test
MT
11/10Proteomics International Laboratories Ltd Secures A Patent in Hong Kong for PromarkerD, First Predictive Diagnostic Test for Diabetic Kidney Disease
CI
10/19Proteomics International-Operated Diagnostics Facility Gets $1.2 Million Funding
MT
SummaryQuotesChartsNewsCalendarCompanyFinancialsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Days
:
Hours
:
Minutes
:
Seconds

Proteomics International Signs Deal for Potential Distribution of Kidney Disease Test PromarkerD in US; Shares Rally 11%

08/08/2022 | 11:35pm EST


ę MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
PROTEOMICS INTERNATIONAL LABORATORIES LIMITED 2.34% 0.875 Delayed Quote.-29.63%
SONIC HEALTHCARE LIMITED 0.00% 31.68 Delayed Quote.-32.06%
All news about PROTEOMICS INTERNATIONAL LABORATORIES LIMITED
11/10Proteomics International Laboratories Secures Hong Kong Patent for Diabetes Test
MT
11/10Proteomics International Laboratories Ltd Secures A Patent in Hong Kong for PromarkerD,..
CI
10/19Proteomics International-Operated Diagnostics Facility Gets $1.2 Million Funding
MT
10/17Proteomics International Laboratories Receives $1.1 Million R&D Tax Rebate
MT
09/27Proteomics Reports Success In Prototype Diagnostic Blood Test
MT
09/26Proteomics International Laboratories Limited Announces Its Prototype Diagnostic Test f..
CI
08/29Proteomics International Laboratories Limited Reports Earnings Results for the Full Yea..
CI
08/15Proteomics International Laboratories Raises $6 Million in Placement; Shares Fall 3%
MT
08/15Proteomics International Laboratories Limited announced that it expects to receive AUD ..
CI
08/08Proteomics International Signs Deal for Potential Distribution of Kidney Disease Test P..
MT
More news
Financials
Sales 2022 3,43 M 2,29 M 2,29 M
Net income 2022 -4,97 M -3,32 M -3,32 M
Net cash 2022 2,11 M 1,41 M 1,41 M
P/E ratio 2022 -19,7x
Yield 2022 -
Capitalization 101 M 67,7 M 67,6 M
EV / Sales 2021 33,5x
EV / Sales 2022 28,0x
Nbr of Employees -
Free-Float 69,4%
Chart PROTEOMICS INTERNATIONAL LABORATORIES LIMITED
Duration : Period :
Proteomics International Laboratories Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PROTEOMICS INTERNATIONAL LABORATORIES LIMITED
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Managers and Directors
Richard Lipscombe Managing Director & Director
Jacqueline Antoinette Christina Gray Chief Financial Officer
Neville Gardiner Non-Executive Chairman
Bringans Scott Head-Research
Kirsten Peters Head-Clinical Studies
Sector and Competitors
1st jan.Capi. (M$)
PROTEOMICS INTERNATIONAL LABORATORIES LIMITED-29.63%66
VERTEX PHARMACEUTICALS43.58%80 935
REGENERON PHARMACEUTICALS, INC.16.58%79 191
BIONTECH SE-37.36%39 245
WUXI APPTEC CO., LTD.-35.85%30 708
GENMAB A/S22.93%29 471